Linden Thomas Advisory Services, LLC Gilead Sciences, Inc. Transaction History
Linden Thomas Advisory Services, LLC
- $732 Billion
- Q3 2024
A detailed history of Linden Thomas Advisory Services, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Linden Thomas Advisory Services, LLC holds 42,901 shares of GILD stock, worth $3.84 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
42,901
Previous 42,054
2.01%
Holding current value
$3.84 Million
Previous $2.89 Billion
24.66%
% of portfolio
0.49%
Previous 0.45%
Shares
8 transactions
Others Institutions Holding GILD
# of Institutions
1,903Shares Held
1.02BCall Options Held
12MPut Options Held
9.02M-
Black Rock Inc. New York, NY121MShares$10.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.3 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.83 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.41 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.31 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $112B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...